aluates Reports

$ 0.0

Automative

Global Vaccine Market Research Report 2026

Published Date: 2026-02-04

Report Code: QYRE-Auto-33X5535

Global Vaccine Market Size Status and Forecast 2021 2027

BUY CHAPTERS

Global Vaccine Market Research Report 2026

Code: QYRE-Auto-33X5535

Report

2026-02-04

Pages:160

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Astrazeneca plc

BioNTech

Boehringer Ingelheim

CCBIO

CSL Limited

CureVac

Elanco

GSK

Hulan Bio

Indian Immunologicals

Merck

Minhai Biotechnology

Mitsubishi Tanabe Pharma

Moderna Therapeutics

Mylan NV

Plumbline Life Sciences

Sanofi

Translate Bio

Walvax Biotechnology

Wuhan Institute of Biological Products

Zoties

Vaccine Market

The global Vaccine market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.

A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body"s immune system to recognize the agent as a threat, destroy it, and keep a record of it so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters. Vaccines can be prophylactic (example: to prevent or ameliorate the effects of a future infection by any natural or "wild" pathogen), or therapeutic (e.g., vaccines against cancer are being investigated).

The North American market for Vaccine is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Vaccine is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The global market for Vaccine in For Adult is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.

Major global companies of Vaccine include AstraZeneca, BioNTech, Boehringer-Ingelheim, CCBIO, CSL, CureVac, Elanco, GSK, Hulan Bio, Indian Immunologicals, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Vaccine market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Vaccine. The Vaccine market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Vaccine market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Vaccine manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Vaccine Market Report

Report Metric	Details
Report Name	Vaccine Market
Segment by Type	Varicella Vaccine Influenza Vaccine Polio Vaccine Hepatitis A Vaccine Rabies Vaccine BCG Vaccine Hepatitis B Pertussis, Diphtheria, Tetanus Pneumococcal Others
Segment by Application	For Adult For Child
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AstraZeneca, BioNTech, Boehringer-Ingelheim, CCBIO, CSL, CureVac, Elanco, GSK, Hulan Bio, Indian Immunologicals, Merck, Minhai Biotechnology, Mitsubishi Tanabe Pharma, Moderna Therapeutics, Mylan, Plumbline Life Sciences, Sanofi, Translate Bio, Walvax Biotechnology, Wuhan Institute of Biological Products, Zoties
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Vaccine companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Vaccine Market report?

Ans: The main players in the Vaccine Market are AstraZeneca, BioNTech, Boehringer-Ingelheim, CCBIO, CSL, CureVac, Elanco, GSK, Hulan Bio, Indian Immunologicals, Merck, Minhai Biotechnology, Mitsubishi Tanabe Pharma, Moderna Therapeutics, Mylan, Plumbline Life Sciences, Sanofi, Translate Bio, Walvax Biotechnology, Wuhan Institute of Biological Products, Zoties

What are the Application segmentation covered in the Vaccine Market report?

Ans: The Applications covered in the Vaccine Market report are For Adult, For Child

What are the Type segmentation covered in the Vaccine Market report?

Ans: The Types covered in the Vaccine Market report are Varicella Vaccine, Influenza Vaccine, Polio Vaccine, Hepatitis A Vaccine, Rabies Vaccine, BCG Vaccine, Hepatitis B, Pertussis, Diphtheria, Tetanus, Pneumococcal, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Vaccine Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Varicella Vaccine

1.2.3 Influenza Vaccine

1.2.4 Polio Vaccine

1.2.5 Hepatitis A Vaccine

1.2.6 Rabies Vaccine

1.2.7 BCG Vaccine

1.2.8 Hepatitis B

1.2.9 Pertussis, Diphtheria, Tetanus

1.2.10 Pneumococcal

1.3 Market by Application

1.3.1 Global Vaccine Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 For Adult

1.3.3 For Child

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Vaccine Market Perspective (2021–2032)

2.2 Global Vaccine Growth Trends by Region

2.2.1 Global Vaccine Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Vaccine Historic Market Size by Region (2021–2026)

2.2.3 Vaccine Forecasted Market Size by Region (2027–2032)

2.3 Vaccine Market Dynamics

2.3.1 Vaccine Industry Trends

2.3.2 Vaccine Market Drivers

2.3.3 Vaccine Market Challenges

2.3.4 Vaccine Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Vaccine Players by Revenue

3.1.1 Global Top Vaccine Players by Revenue (2021–2026)

3.1.2 Global Vaccine Revenue Market Share by Players (2021–2026)

3.2 Global Top Vaccine Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Vaccine Revenue

3.4 Global Vaccine Market Concentration Ratio

3.4.1 Global Vaccine Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Vaccine Revenue in 2025

3.5 Global Key Players of Vaccine Head Offices and Areas Served

3.6 Global Key Players of Vaccine, Products and Applications

3.7 Global Key Players of Vaccine, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Vaccine Breakdown Data by Type

4.1 Global Vaccine Historic Market Size by Type (2021–2026)

4.2 Global Vaccine Forecasted Market Size by Type (2027–2032)

5 Vaccine Breakdown Data by Application

5.1 Global Vaccine Historic Market Size by Application (2021–2026)

5.2 Global Vaccine Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Vaccine Market Size (2021–2032)

6.2 North America Vaccine Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Vaccine Market Size by Country (2021–2026)

6.4 North America Vaccine Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Vaccine Market Size (2021–2032)

7.2 Europe Vaccine Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Vaccine Market Size by Country (2021–2026)

7.4 Europe Vaccine Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Vaccine Market Size (2021–2032)

8.2 Asia-Pacific Vaccine Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Vaccine Market Size by Region (2021–2026)

8.4 Asia-Pacific Vaccine Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Vaccine Market Size (2021–2032)

9.2 Latin America Vaccine Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Vaccine Market Size by Country (2021–2026)

9.4 Latin America Vaccine Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Vaccine Market Size (2021–2032)

10.2 Middle East & Africa Vaccine Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Vaccine Market Size by Country (2021–2026)

10.4 Middle East & Africa Vaccine Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 AstraZeneca

11.1.1 AstraZeneca Company Details

11.1.2 AstraZeneca Business Overview

11.1.3 AstraZeneca Vaccine Introduction

11.1.4 AstraZeneca Revenue in Vaccine Business (2021–2026)

11.1.5 AstraZeneca Recent Development

11.2 BioNTech

11.2.1 BioNTech Company Details

11.2.2 BioNTech Business Overview

11.2.3 BioNTech Vaccine Introduction

11.2.4 BioNTech Revenue in Vaccine Business (2021–2026)

11.2.5 BioNTech Recent Development

11.3 Boehringer-Ingelheim

11.3.1 Boehringer-Ingelheim Company Details

11.3.2 Boehringer-Ingelheim Business Overview

11.3.3 Boehringer-Ingelheim Vaccine Introduction

11.3.4 Boehringer-Ingelheim Revenue in Vaccine Business (2021–2026)

11.3.5 Boehringer-Ingelheim Recent Development

11.4 CCBIO

11.4.1 CCBIO Company Details

11.4.2 CCBIO Business Overview

11.4.3 CCBIO Vaccine Introduction

11.4.4 CCBIO Revenue in Vaccine Business (2021–2026)

11.4.5 CCBIO Recent Development

11.5 CSL

11.5.1 CSL Company Details

11.5.2 CSL Business Overview

11.5.3 CSL Vaccine Introduction

11.5.4 CSL Revenue in Vaccine Business (2021–2026)

11.5.5 CSL Recent Development

11.6 CureVac

11.6.1 CureVac Company Details

11.6.2 CureVac Business Overview

11.6.3 CureVac Vaccine Introduction

11.6.4 CureVac Revenue in Vaccine Business (2021–2026)

11.6.5 CureVac Recent Development

11.7 Elanco

11.7.1 Elanco Company Details

11.7.2 Elanco Business Overview

11.7.3 Elanco Vaccine Introduction

11.7.4 Elanco Revenue in Vaccine Business (2021–2026)

11.7.5 Elanco Recent Development

11.8 GSK

11.8.1 GSK Company Details

11.8.2 GSK Business Overview

11.8.3 GSK Vaccine Introduction

11.8.4 GSK Revenue in Vaccine Business (2021–2026)

11.8.5 GSK Recent Development

11.9 Hulan Bio

11.9.1 Hulan Bio Company Details

11.9.2 Hulan Bio Business Overview

11.9.3 Hulan Bio Vaccine Introduction

11.9.4 Hulan Bio Revenue in Vaccine Business (2021–2026)

11.9.5 Hulan Bio Recent Development

11.10 Indian Immunologicals

11.10.1 Indian Immunologicals Company Details

11.10.2 Indian Immunologicals Business Overview

11.10.3 Indian Immunologicals Vaccine Introduction

11.10.4 Indian Immunologicals Revenue in Vaccine Business (2021–2026)

11.10.5 Indian Immunologicals Recent Development

11.11 Merck

11.11.1 Merck Company Details

11.11.2 Merck Business Overview

11.11.3 Merck Vaccine Introduction

11.11.4 Merck Revenue in Vaccine Business (2021–2026)

11.11.5 Merck Recent Development

11.12 Minhai Biotechnology

11.12.1 Minhai Biotechnology Company Details

11.12.2 Minhai Biotechnology Business Overview

11.12.3 Minhai Biotechnology Vaccine Introduction

11.12.4 Minhai Biotechnology Revenue in Vaccine Business (2021–2026)

11.12.5 Minhai Biotechnology Recent Development

11.13 Mitsubishi Tanabe Pharma

11.13.1 Mitsubishi Tanabe Pharma Company Details

11.13.2 Mitsubishi Tanabe Pharma Business Overview

11.13.3 Mitsubishi Tanabe Pharma Vaccine Introduction

11.13.4 Mitsubishi Tanabe Pharma Revenue in Vaccine Business (2021–2026)

11.13.5 Mitsubishi Tanabe Pharma Recent Development

11.14 Moderna Therapeutics

11.14.1 Moderna Therapeutics Company Details

11.14.2 Moderna Therapeutics Business Overview

11.14.3 Moderna Therapeutics Vaccine Introduction

11.14.4 Moderna Therapeutics Revenue in Vaccine Business (2021–2026)

11.14.5 Moderna Therapeutics Recent Development

11.15 Mylan

11.15.1 Mylan Company Details

11.15.2 Mylan Business Overview

11.15.3 Mylan Vaccine Introduction

11.15.4 Mylan Revenue in Vaccine Business (2021–2026)

11.15.5 Mylan Recent Development

11.16 Plumbline Life Sciences

11.16.1 Plumbline Life Sciences Company Details

11.16.2 Plumbline Life Sciences Business Overview

11.16.3 Plumbline Life Sciences Vaccine Introduction

11.16.4 Plumbline Life Sciences Revenue in Vaccine Business (2021–2026)

11.16.5 Plumbline Life Sciences Recent Development

11.17 Sanofi

11.17.1 Sanofi Company Details

11.17.2 Sanofi Business Overview

11.17.3 Sanofi Vaccine Introduction

11.17.4 Sanofi Revenue in Vaccine Business (2021–2026)

11.17.5 Sanofi Recent Development

11.18 Translate Bio

11.18.1 Translate Bio Company Details

11.18.2 Translate Bio Business Overview

11.18.3 Translate Bio Vaccine Introduction

11.18.4 Translate Bio Revenue in Vaccine Business (2021–2026)

11.18.5 Translate Bio Recent Development

11.19 Walvax Biotechnology

11.19.1 Walvax Biotechnology Company Details

11.19.2 Walvax Biotechnology Business Overview

11.19.3 Walvax Biotechnology Vaccine Introduction

11.19.4 Walvax Biotechnology Revenue in Vaccine Business (2021–2026)

11.19.5 Walvax Biotechnology Recent Development

11.20 Wuhan Institute of Biological Products

11.20.1 Wuhan Institute of Biological Products Company Details

11.20.2 Wuhan Institute of Biological Products Business Overview

11.20.3 Wuhan Institute of Biological Products Vaccine Introduction

11.20.4 Wuhan Institute of Biological Products Revenue in Vaccine Business (2021–2026)

11.20.5 Wuhan Institute of Biological Products Recent Development

11.21 Zoties

11.21.1 Zoties Company Details

11.21.2 Zoties Business Overview

11.21.3 Zoties Vaccine Introduction

11.21.4 Zoties Revenue in Vaccine Business (2021–2026)

11.21.5 Zoties Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Astrazeneca plc

BioNTech

Boehringer Ingelheim

CCBIO

CSL Limited

CureVac

Elanco

GSK

Hulan Bio

Indian Immunologicals

Merck

Minhai Biotechnology

Mitsubishi Tanabe Pharma

Moderna Therapeutics

Mylan NV

Plumbline Life Sciences

Sanofi

Translate Bio

Walvax Biotechnology

Wuhan Institute of Biological Products

Zoties

List of Tables

Table 1. Global Vaccine Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Varicella Vaccine

Table 3. Key Players of Influenza Vaccine

Table 4. Key Players of Polio Vaccine

Table 5. Key Players of Hepatitis A Vaccine

Table 6. Key Players of Rabies Vaccine

Table 7. Key Players of BCG Vaccine

Table 8. Key Players of Hepatitis B

Table 9. Global Vaccine Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 10. Global Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 11. Global Vaccine Market Size by Region (US$ Million), 2021–2026

Table 12. Global Vaccine Market Share by Region (2021–2026)

Table 13. Global Vaccine Forecasted Market Size by Region (US$ Million), 2027–2032

Table 14. Global Vaccine Market Share by Region (2027–2032)

Table 15. Vaccine Market Trends

Table 16. Vaccine Market Drivers

Table 17. Vaccine Market Challenges

Table 18. Vaccine Market Restraints

Table 19. Global Vaccine Revenue by Players (US$ Million), 2021–2026

Table 20. Global Vaccine Market Share by Players (2021–2026)

Table 21. Global Top Vaccine Players by Tier (Tier 1, Tier 2, and Tier 3), based on Vaccine Revenue, 2025

Table 22. Ranking of Global Top Vaccine Companies by Revenue (US$ Million) in 2025

Table 23. Global 5 Largest Players Market Share by Vaccine Revenue (CR5 and HHI), 2021–2026

Table 24. Global Key Players of Vaccine, Headquarters and Area Served

Table 25. Global Key Players of Vaccine, Products and Applications

Table 26. Global Key Players of Vaccine, Date of General Availability (GA)

Table 27. Mergers and Acquisitions, Expansion Plans

Table 28. Global Vaccine Market Size by Type (US$ Million), 2021–2026

Table 29. Global Vaccine Revenue Market Share by Type (2021–2026)

Table 30. Global Vaccine Forecasted Market Size by Type (US$ Million), 2027–2032

Table 31. Global Vaccine Revenue Market Share by Type (2027–2032)

Table 32. Global Vaccine Market Size by Application (US$ Million), 2021–2026

Table 33. Global Vaccine Revenue Market Share by Application (2021–2026)

Table 34. Global Vaccine Forecasted Market Size by Application (US$ Million), 2027–2032

Table 35. Global Vaccine Revenue Market Share by Application (2027–2032)

Table 36. North America Vaccine Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 37. North America Vaccine Market Size by Country (US$ Million), 2021–2026

Table 38. North America Vaccine Market Size by Country (US$ Million), 2027–2032

Table 39. Europe Vaccine Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 40. Europe Vaccine Market Size by Country (US$ Million), 2021–2026

Table 41. Europe Vaccine Market Size by Country (US$ Million), 2027–2032

Table 42. Asia-Pacific Vaccine Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 43. Asia-Pacific Vaccine Market Size by Region (US$ Million), 2021–2026

Table 44. Asia-Pacific Vaccine Market Size by Region (US$ Million), 2027–2032

Table 45. Latin America Vaccine Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 46. Latin America Vaccine Market Size by Country (US$ Million), 2021–2026

Table 47. Latin America Vaccine Market Size by Country (US$ Million), 2027–2032

Table 48. Middle East & Africa Vaccine Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 49. Middle East & Africa Vaccine Market Size by Country (US$ Million), 2021–2026

Table 50. Middle East & Africa Vaccine Market Size by Country (US$ Million), 2027–2032

Table 51. AstraZeneca Company Details

Table 52. AstraZeneca Business Overview

Table 53. AstraZeneca Vaccine Product

Table 54. AstraZeneca Revenue in Vaccine Business (US$ Million), 2021–2026

Table 55. AstraZeneca Recent Development

Table 56. BioNTech Company Details

Table 57. BioNTech Business Overview

Table 58. BioNTech Vaccine Product

Table 59. BioNTech Revenue in Vaccine Business (US$ Million), 2021–2026

Table 60. BioNTech Recent Development

Table 61. Boehringer-Ingelheim Company Details

Table 62. Boehringer-Ingelheim Business Overview

Table 63. Boehringer-Ingelheim Vaccine Product

Table 64. Boehringer-Ingelheim Revenue in Vaccine Business (US$ Million), 2021–2026

Table 65. Boehringer-Ingelheim Recent Development

Table 66. CCBIO Company Details

Table 67. CCBIO Business Overview

Table 68. CCBIO Vaccine Product

Table 69. CCBIO Revenue in Vaccine Business (US$ Million), 2021–2026

Table 70. CCBIO Recent Development

Table 71. CSL Company Details

Table 72. CSL Business Overview

Table 73. CSL Vaccine Product

Table 74. CSL Revenue in Vaccine Business (US$ Million), 2021–2026

Table 75. CSL Recent Development

Table 76. CureVac Company Details

Table 77. CureVac Business Overview

Table 78. CureVac Vaccine Product

Table 79. CureVac Revenue in Vaccine Business (US$ Million), 2021–2026

Table 80. CureVac Recent Development

Table 81. Elanco Company Details

Table 82. Elanco Business Overview

Table 83. Elanco Vaccine Product

Table 84. Elanco Revenue in Vaccine Business (US$ Million), 2021–2026

Table 85. Elanco Recent Development

Table 86. GSK Company Details

Table 87. GSK Business Overview

Table 88. GSK Vaccine Product

Table 89. GSK Revenue in Vaccine Business (US$ Million), 2021–2026

Table 90. GSK Recent Development

Table 91. Hulan Bio Company Details

Table 92. Hulan Bio Business Overview

Table 93. Hulan Bio Vaccine Product

Table 94. Hulan Bio Revenue in Vaccine Business (US$ Million), 2021–2026

Table 95. Hulan Bio Recent Development

Table 96. Indian Immunologicals Company Details

Table 97. Indian Immunologicals Business Overview

Table 98. Indian Immunologicals Vaccine Product

Table 99. Indian Immunologicals Revenue in Vaccine Business (US$ Million), 2021–2026

Table 100. Indian Immunologicals Recent Development

Table 101. Merck Company Details

Table 102. Merck Business Overview

Table 103. Merck Vaccine Product

Table 104. Merck Revenue in Vaccine Business (US$ Million), 2021–2026

Table 105. Merck Recent Development

Table 106. Minhai Biotechnology Company Details

Table 107. Minhai Biotechnology Business Overview

Table 108. Minhai Biotechnology Vaccine Product

Table 109. Minhai Biotechnology Revenue in Vaccine Business (US$ Million), 2021–2026

Table 110. Minhai Biotechnology Recent Development

Table 111. Mitsubishi Tanabe Pharma Company Details

Table 112. Mitsubishi Tanabe Pharma Business Overview

Table 113. Mitsubishi Tanabe Pharma Vaccine Product

Table 114. Mitsubishi Tanabe Pharma Revenue in Vaccine Business (US$ Million), 2021–2026

Table 115. Mitsubishi Tanabe Pharma Recent Development

Table 116. Moderna Therapeutics Company Details

Table 117. Moderna Therapeutics Business Overview

Table 118. Moderna Therapeutics Vaccine Product

Table 119. Moderna Therapeutics Revenue in Vaccine Business (US$ Million), 2021–2026

Table 120. Moderna Therapeutics Recent Development

Table 121. Mylan Company Details

Table 122. Mylan Business Overview

Table 123. Mylan Vaccine Product

Table 124. Mylan Revenue in Vaccine Business (US$ Million), 2021–2026

Table 125. Mylan Recent Development

Table 126. Plumbline Life Sciences Company Details

Table 127. Plumbline Life Sciences Business Overview

Table 128. Plumbline Life Sciences Vaccine Product

Table 129. Plumbline Life Sciences Revenue in Vaccine Business (US$ Million), 2021–2026

Table 130. Plumbline Life Sciences Recent Development

Table 131. Sanofi Company Details

Table 132. Sanofi Business Overview

Table 133. Sanofi Vaccine Product

Table 134. Sanofi Revenue in Vaccine Business (US$ Million), 2021–2026

Table 135. Sanofi Recent Development

Table 136. Translate Bio Company Details

Table 137. Translate Bio Business Overview

Table 138. Translate Bio Vaccine Product

Table 139. Translate Bio Revenue in Vaccine Business (US$ Million), 2021–2026

Table 140. Translate Bio Recent Development

Table 141. Walvax Biotechnology Company Details

Table 142. Walvax Biotechnology Business Overview

Table 143. Walvax Biotechnology Vaccine Product

Table 144. Walvax Biotechnology Revenue in Vaccine Business (US$ Million), 2021–2026

Table 145. Walvax Biotechnology Recent Development

Table 146. Wuhan Institute of Biological Products Company Details

Table 147. Wuhan Institute of Biological Products Business Overview

Table 148. Wuhan Institute of Biological Products Vaccine Product

Table 149. Wuhan Institute of Biological Products Revenue in Vaccine Business (US$ Million), 2021–2026

Table 150. Wuhan Institute of Biological Products Recent Development

Table 151. Zoties Company Details

Table 152. Zoties Business Overview

Table 153. Zoties Vaccine Product

Table 154. Zoties Revenue in Vaccine Business (US$ Million), 2021–2026

Table 155. Zoties Recent Development

Table 156. Research Programs/Design for This Report

Table 157. Key Data Information from Secondary Sources

Table 158. Key Data Information from Primary Sources

Table 159. Authors List of This Report

List of Figures

Figure 1. Vaccine Picture

Figure 2. Global Vaccine Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Vaccine Market Share by Type: 2025 vs 2032

Figure 4. Varicella Vaccine Features

Figure 5. Influenza Vaccine Features

Figure 6. Polio Vaccine Features

Figure 7. Hepatitis A Vaccine Features

Figure 8. Rabies Vaccine Features

Figure 9. BCG Vaccine Features

Figure 10. Hepatitis B Features

Figure 11. Pertussis, Diphtheria, Tetanus Features

Figure 12. Pneumococcal Features

Figure 13. Global Vaccine Market Size by Application (US$ Million), 2021–2032

Figure 14. Global Vaccine Market Share by Application: 2025 vs 2032

Figure 15. For Adult Case Studies

Figure 16. For Child Case Studies

Figure 17. Vaccine Report Years Considered

Figure 18. Global Vaccine Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 19. Global Vaccine Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 20. Global Vaccine Market Share by Region: 2025 vs 2032

Figure 21. Global Vaccine Market Share by Players in 2025

Figure 22. Global Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 23. The Top 10 and 5 Players Market Share by Vaccine Revenue in 2025

Figure 24. North America Vaccine Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. North America Vaccine Market Share by Country (2021–2032)

Figure 26. United States Vaccine Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. Canada Vaccine Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Europe Vaccine Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Europe Vaccine Market Share by Country (2021–2032)

Figure 30. Germany Vaccine Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. France Vaccine Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. U.K. Vaccine Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Italy Vaccine Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Russia Vaccine Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Ireland Vaccine Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Asia-Pacific Vaccine Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Asia-Pacific Vaccine Market Share by Region (2021–2032)

Figure 38. China Vaccine Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Japan Vaccine Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. South Korea Vaccine Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Southeast Asia Vaccine Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. India Vaccine Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Australia & New Zealand Vaccine Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Latin America Vaccine Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Latin America Vaccine Market Share by Country (2021–2032)

Figure 46. Mexico Vaccine Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Brazil Vaccine Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Middle East & Africa Vaccine Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. Middle East & Africa Vaccine Market Share by Country (2021–2032)

Figure 50. Israel Vaccine Market Size YoY Growth (US$ Million), 2021–2032

Figure 51. Saudi Arabia Vaccine Market Size YoY Growth (US$ Million), 2021–2032

Figure 52. UAE Vaccine Market Size YoY Growth (US$ Million), 2021–2032

Figure 53. AstraZeneca Revenue Growth Rate in Vaccine Business (2021–2026)

Figure 54. BioNTech Revenue Growth Rate in Vaccine Business (2021–2026)

Figure 55. Boehringer-Ingelheim Revenue Growth Rate in Vaccine Business (2021–2026)

Figure 56. CCBIO Revenue Growth Rate in Vaccine Business (2021–2026)

Figure 57. CSL Revenue Growth Rate in Vaccine Business (2021–2026)

Figure 58. CureVac Revenue Growth Rate in Vaccine Business (2021–2026)

Figure 59. Elanco Revenue Growth Rate in Vaccine Business (2021–2026)

Figure 60. GSK Revenue Growth Rate in Vaccine Business (2021–2026)

Figure 61. Hulan Bio Revenue Growth Rate in Vaccine Business (2021–2026)

Figure 62. Indian Immunologicals Revenue Growth Rate in Vaccine Business (2021–2026)

Figure 63. Merck Revenue Growth Rate in Vaccine Business (2021–2026)

Figure 64. Minhai Biotechnology Revenue Growth Rate in Vaccine Business (2021–2026)

Figure 65. Mitsubishi Tanabe Pharma Revenue Growth Rate in Vaccine Business (2021–2026)

Figure 66. Moderna Therapeutics Revenue Growth Rate in Vaccine Business (2021–2026)

Figure 67. Mylan Revenue Growth Rate in Vaccine Business (2021–2026)

Figure 68. Plumbline Life Sciences Revenue Growth Rate in Vaccine Business (2021–2026)

Figure 69. Sanofi Revenue Growth Rate in Vaccine Business (2021–2026)

Figure 70. Translate Bio Revenue Growth Rate in Vaccine Business (2021–2026)

Figure 71. Walvax Biotechnology Revenue Growth Rate in Vaccine Business (2021–2026)

Figure 72. Wuhan Institute of Biological Products Revenue Growth Rate in Vaccine Business (2021–2026)

Figure 73. Zoties Revenue Growth Rate in Vaccine Business (2021–2026)

Figure 74. Bottom-up and Top-down Approaches for This Report

Figure 75. Data Triangulation

Figure 76. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Vaccines for the Elderly Market Research Report 2024

Global Multiple Vaccine Market Research Report 2024

Global Seasonal Vaccines Market Research Report 2024

Global HIV Vaccine Market Research Report 2025

Global Consumption Type Vaccine Market Research Report 2024

Global Vaccine Management Software Market Research Report 2025

Global Adult and Pediatric Vaccines Market Research Report 2024

Global Vaccination Device Market Research Report 2024

Vaccine Container Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Human Vaccine Adjuvants Market

mRNA Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Commercial Fish Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global HIV and AIDS Vaccine Market Research Report 2024

Global Norovirus Vaccine Market Research Report 2024

Global Biopharmaceutical and Vaccines Market Research Report 2024

Global Electric Vaccine Vehicle Market Research Report 2025

Vaccine Refrigerant Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Vaccine Management Solution Market Research Report 2024

Live and Attenuated Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions